Epoetin alfa: biosimilar. Copied, with biosimilar status.
The first copy of Eprex, a product containing epoetin alfa, has been marketed in France, under the name Binocrit.
D017277:Drug Approval; D000068817:Epoetin Alfa; D004921:Erythropoietin / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D005602:France; D006801:Humans; D007676:Kidney Failure, Chronic / Q000188:drug therapy; D011994:Recombinant Proteins; D013810:Therapeutic Equivalency
D011994:Recombinant Proteins; D004921:Erythropoietin; D000068817:Epoetin Alfa